
Biotech company Orphazyme has been granted another new deadline for the release of its full-year 2021 report, the company has announced in a press release on Tuesday.
Upon request, the Danish Business Authority has approved an extension to the deadline for annual report’s filing, which follows the initiation of Orphazyme’s in-court restructuring proceedings.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app